EDISON, N.J., Jan. 5 /PRNewswire-FirstCall/ -- New Brunswick Scientific Co., Inc. (NBS) , a leading provider of a comprehensive line of research equipment and scientific instrumentation for use in the life science industry, today announced the selection of the Oracle(R) E-Business Suite to align its worldwide operations -- including sales, marketing, finance, design, manufacturing, logistics and distribution -- under a unified enterprise information system.
“NBS’ senior management and Board of Directors determined that a global enterprise resource planning (ERP) solution was needed to enhance efficiencies and support future growth,” said Vice President of Manufacturing Operations John Powers. “Oracle clearly demonstrated its understanding of our current mission critical requirements as well as our need for future scalability in our IT capabilities.”
He explained, “Previously, NBS ran with a series of disparate information systems -- in part as a result of recent acquisitions, but also as its legacy systems lacked sufficient scale and breadth for current information needs. Faced with Sarbanes Oxley Section 404 compliance, our aggressive new-product development schedule and the need for broadened front-end CRM and back-end financial tools, we believe that Oracle’s vertical position in the life science sector and seamless workflows will provide us a strong infrastructure on which to build. We were impressed by Oracle’s seamless technology stack, comprehensive application suite and extensive offering of adjunct modules, which we view as optimization tools for our current and future application requirements. This initiative further enhances our use of information technology to achieve economies of scale and increased operational efficiencies, benefiting our consolidated operations in terms of further improvements in productivity and customer integration.”
The Company’s comprehensive plan for a sequential rollout across its global platform begins with U.S. operations in 2006, followed by all European and Asian operations in 2007.
To be added to New Brunswick Scientific’s e-mail distribution list, please click on the link below:
http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html
About New Brunswick Scientific
New Brunswick Scientific Co., Inc., is a leading global provider of a comprehensive line of research equipment and scientific instrumentation for use in the life science industry. The Company’s products are used in the creation, maintenance and control of physical and biochemical environments required for the growth, detection and storage of microorganisms for medical, biological and chemical applications, as well as environmental research and commercial product development. NBS is a forerunner in the research and development of pioneering equipment to meet the challenges of new areas of advancement in life science. Established in 1946, New Brunswick Scientific is headquartered in Edison, New Jersey, with sales and distribution facilities strategically located in the United States, Europe and Asia. For more information, please visit http://www.nbsc.com .
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements may be identified by words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of the Company. The forward-looking statements involve a number of risks and uncertainties, including but not limited to: changes in economic conditions, demand for the Company’s products, pricing pressures, intense competition in the industries in which the Company operates, the need for the Company to keep pace with technological developments and respond in a timely manner to changes in customer needs, the Company’s dependence on third-party suppliers, the effect on foreign sales of currency fluctuations, acceptance of new products, the labor relations of the Company and its customers and other factors identified in the Company’s Securities and Exchange Commission filings. Forward-looking statements are based on management’s current expectations and assumptions, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from these expectations and assumptions due to changes in global political, economic, business, competitive, market, regulatory and other factors. The Company undertakes no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise.
Oracle, JD Edwards, and PeopleSoft are registered trademarks of Oracle Corporation and/or its affiliates.
New Brunswick Scientific Co., Inc.
CONTACT: John Powers, V.P., Manufacturing Operations of New BrunswickScientific Co., Inc., +1-732.650.2006, jpowers@nbsc.com; or Matthew J.Dennis, CFA, NBS Investor Relations of Clear Perspective Group, LLC,+1-440-353-0552, mdennis@cpg-llc.com
Web site: http://www.nbsc.com/
